tiprankstipranks
Trending News
More News >
CareCloud (CCLD)
NASDAQ:CCLD

CareCloud (CCLD) AI Stock Analysis

Compare
711 Followers

Top Page

CCLD

CareCloud

(NASDAQ:CCLD)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 4o)
Rating:61Neutral
Price Target:
$3.50
▲(16.28% Upside)
CareCloud's overall stock score reflects a solid financial performance and positive earnings call insights, tempered by a high valuation and mixed technical indicators. The company's strategic acquisitions and AI advancements are promising, but the high P/E ratio and potential overbought technical conditions suggest caution. The company's ability to manage debt and leverage growth opportunities will be crucial for future performance.

CareCloud (CCLD) vs. SPDR S&P 500 ETF (SPY)

CareCloud Business Overview & Revenue Model

Company DescriptionCareCloud (CCLD) is a healthcare technology company that provides a comprehensive suite of solutions designed to enhance the operational efficiency of medical practices and healthcare organizations. Operating primarily in the healthcare sector, CareCloud specializes in cloud-based software solutions, including electronic health records (EHR), practice management, revenue cycle management, and telehealth services. The company aims to streamline healthcare workflows and improve patient engagement through innovative technology.
How the Company Makes MoneyCareCloud generates revenue through multiple key streams, primarily by offering subscription-based services for its cloud-based software products. The company's EHR and practice management systems are available via monthly subscription fees, allowing healthcare providers to access essential tools for managing patient information and billing processes. Additionally, CareCloud earns revenue through its revenue cycle management services, which include billing and collections, helping practices optimize their financial performance. The company may also benefit from partnerships with healthcare organizations that seek integrated solutions, further enhancing its market reach and driving sales. Significant factors contributing to its earnings include the growing demand for digital health solutions, the shift towards value-based care, and the increasing adoption of telehealth services, especially in the wake of the COVID-19 pandemic.

CareCloud Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 27, 2026
Earnings Call Sentiment Positive
The earnings call highlighted strong revenue growth, strategic acquisitions, and advancements in AI capabilities, driving profitability and positive earnings. However, there is some concern regarding the debt incurred from the Medsphere acquisition, although the company is addressing it promptly.
Q3-2025 Updates
Positive Updates
Revenue and Growth
CareCloud delivered revenue of $31.1 million for Q3 2025, an increase of 9% from the same period last year. The company also raised full year revenue guidance to $117 million to $119 million, up from the previous $111 million to $114 million.
Strategic Acquisitions
CareCloud completed two strategic acquisitions: Medsphere and Map App. Medsphere expands CareCloud's reach into the hospital market, while Map App enhances analytics and benchmarking capabilities.
AI Milestones
Launched the Agentic AI front desk solution, which successfully handled over 70% of incoming patient calls end-to-end without human intervention and achieved over 80% success in appointment scheduling and related tasks.
Profitability and Earnings
GAAP EPS improved by $0.08 year-over-year to $0.04, and adjusted EBITDA increased 13% to $7.7 million. The company reported a GAAP net income of $3.1 million for Q3 2025.
Negative Updates
Debt from Medsphere Acquisition
The acquisition of Medsphere was partially funded through a line of credit, resulting in a $4.9 million balance as of the latest update. However, the company plans to pay off the remaining balance quickly.
Company Guidance
During the third quarter of 2025, CareCloud delivered significant growth and updated its financial guidance. The company raised its full-year revenue guidance to between $117 million and $119 million, up from the initial range of $111 million to $114 million. They also reaffirmed their adjusted EBITDA guidance at $26 million to $28 million and GAAP EPS guidance of $0.10 to $0.13. For the third quarter specifically, CareCloud reported revenue of $31.1 million, marking a 9% increase compared to the same period last year. The company's adjusted EBITDA for the quarter was $7.7 million, reflecting a 13% year-over-year increase, while GAAP EPS improved by $0.08 year-over-year to $0.04. These results were driven by strategic acquisitions and advancements in AI capabilities, which are expected to create further value and operating leverage.

CareCloud Financial Statement Overview

Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
68
Positive
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

CareCloud Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.01
Price Trends
50DMA
3.13
Negative
100DMA
3.19
Negative
200DMA
2.58
Positive
Market Momentum
MACD
>-0.01
Positive
RSI
41.88
Neutral
STOCH
12.47
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCLD, the sentiment is Negative. The current price of 3.01 is below the 20-day moving average (MA) of 3.16, below the 50-day MA of 3.13, and above the 200-day MA of 2.58, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 41.88 is Neutral, neither overbought nor oversold. The STOCH value of 12.47 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CCLD.

CareCloud Peers Comparison

Overall Rating
UnderperformOutperform
Sector (―)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$131.01M74.6921.49%2.97%
49
Neutral
$65.56M-77.01-2.94%42.60%67.76%
48
Neutral
$75.14M-0.63-38.35%4.33%50.50%
34
Underperform
$89.21M-3.68-792.01%4.31%
* Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CCLD
CareCloud
3.04
-0.80
-20.83%
AMWL
American Well
4.55
-2.92
-39.09%
FORA
Forian
2.11
0.06
2.93%
ONMD
OneMedNet
1.27
-0.19
-13.01%
BEAT
HeartBeam
2.44
0.28
12.96%
EUDA
EUDA Health Holdings
2.45
-1.99
-44.82%

CareCloud Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
CareCloud Mourns Loss of Director John Daly
Negative
Nov 26, 2025

CareCloud announced the passing of Mr. John N. Daly, a respected director of the company, who served since July 2014, on November 24, 2025. His passing marks a significant loss for the company, impacting its leadership and potentially affecting its strategic direction.

DividendsFinancial Disclosures
CareCloud Plans Double Dividends for Series B Stock
Positive
Nov 10, 2025

CareCloud announced a plan to pay double monthly dividends on its Series B Preferred Stock starting January 2026, aiming to address 14 months of accumulated unpaid dividends from November 2023 through December 2024. This decision reflects CareCloud’s successful financial turnaround, with improved margins and growing recurring revenues, and is designed to fulfill obligations to shareholders without diluting common stock. The double payments are expected to continue until the arrears are fully satisfied, anticipated by the end of the first quarter of 2027.

Business Operations and StrategyFinancial Disclosures
CareCloud Reports Strong Q3 2025 Financial Results
Positive
Nov 6, 2025

On November 6, 2025, CareCloud announced its third-quarter 2025 financial results, reporting a 9% year-over-year revenue increase and its sixth consecutive quarter of positive GAAP net income. The company raised its full-year revenue guidance to $117-$119 million, driven by successful acquisitions and AI initiatives, positioning itself as a growing leader in the healthcare technology sector.

Delistings and Listing ChangesDividends
CareCloud Declares Dividends for Preferred Stock
Positive
Oct 7, 2025

On October 7, 2025, CareCloud announced that its Board of Directors declared monthly cash dividends for its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock for October, November, and December 2025. This decision reflects the company’s commitment to providing consistent returns to its shareholders, despite the recent mandatory conversion of Series A Preferred Stock into common stock and its subsequent delisting from Nasdaq. The dividends are part of CareCloud’s strategy to maintain shareholder value and confidence in its financial stability.

Private Placements and FinancingM&A TransactionsBusiness Operations and Strategy
CareCloud Secures $10M Credit Facility from Provident Bank
Positive
Sep 9, 2025

On September 3, 2025, CareCloud, Inc. secured a $10 million credit facility from Provident Bank, replacing a previous obligation to Wells Fargo. This move, which involved borrowing $8.3 million to support the acquisition of Medsphere Systems Corp., provides more favorable terms and strengthens CareCloud’s liquidity, enhancing its ability to execute its growth strategy.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 09, 2025